Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.
Subscribe to:
Post Comments (Atom)
< + > Is AI Headed for a Blockchain-Style Letdown? CVS Health’s Tilak Mandadi Doesn’t Think So
Healthcare keeps chasing its next big breakthrough. Right now, that spotlight is firmly on AI – touted as the industry’s next big thing. But...
No comments:
Post a Comment